Physician

Ann Aleman Weinmann, MD

According to 2025 Medicare claims, Ann Weinmann, MD (NPI: 1982660338) practices internal medicine in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is ANN M ALEMAN-WEINMANN MD., FACP PA (NPI: 1467418996; TIN: 742617515) and primary practice location at 78411-2603.

Weinmann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 203 traditional Medicare patients, billed 40,280 HCPCS/CPT codes, and received $422,677 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 11,611 prescription claims across 1,002 beneficiaries totaling $9,652,399 in drug costs, led by Enbrel Mini (Etanercept). 2017 DME data shows 15 claims. Open Payments data shows 92 records totaling $2,375. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,849,291 to $9,652,399. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $3,396 to $97.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	328	25,004	$323,694
2016	302	36,682	$502,147
2017	277	40,996	$538,453
2018	271	38,813	$517,393
2019	271	33,281	$492,582
2020	246	37,155	$613,714
2021	221	38,003	$483,619
2022	208	43,081	$495,731
2023	203	41,037	$467,799
2024	203	40,280	$422,677

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	467	6,293	$1,849,291
2016	451	5,909	$1,553,030
2017	503	5,933	$1,899,483
2018	587	6,402	$2,327,378
2019	642	6,813	$3,151,144
2020	967	9,698	$5,322,416
2021	1,052	10,859	$7,316,539
2022	1,013	10,482	$8,664,979
2023	974	10,584	$8,720,406
2024	1,002	11,611	$9,652,399

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	35	$694
2016	N/R	24	$447
2017	N/R	15	$378
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	48	48	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	187	379	$85
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	49	153	$52
77080	Dxa bone density measurement of hip, pelvis, spine	94	94	$35
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	156	327	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Mini	Etanercept	260	7,364	$2,159,812
Humira(Cf) Pen	Adalimumab	191	5,394	$1,445,753
Otezla	Apremilast	144	4,440	$751,579
Xeljanz Xr	Tofacitinib Citrate	113	3,390	$729,435
Skyrizi Pen	Risankizumab-Rzaa	25	1,824	$617,974

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	92	$2,375	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ann Aleman Weinmann, MD?

Tedicare shows public-source Medicare data for Ann Aleman Weinmann, MD (NPI 1982660338), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ann Aleman Weinmann, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ann Aleman Weinmann, MD?

Ann Aleman Weinmann, MD is linked to ANN M ALEMAN-WEINMANN MD., FACP PA (billing NPI 1467418996) in the available physician profile data.

Does Ann Aleman Weinmann, MD have Open Payments data?

Ann Aleman Weinmann, MD has 92 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.